Table 3.
Screen | Baseline (Day 0) Treatment 1 | 24 hours (+/−2) Phone Visit | Day 3 (+/−1) Treatment 2 | Day 7 (+/−1) Treatment 3 | Day 28 (+/−1) Treatment 4 | Day 56 (+/−1) Treatment 5 | |
---|---|---|---|---|---|---|---|
Inclusion/exclusion criteria | × | ||||||
Written informed consent | × | ||||||
Medical history | × | ||||||
Pregnancy Test1 | × | × | |||||
Concomitant medications query | × | × | × | × | × | × | × |
Adverse event query | × | × | × | × | × | × | |
Investigator evaluation | × | × | × | × | × | ||
Clinical photography | × | × | × | × | × | ||
Treatment utilizing stated parameters | × | × | × | × | × | ||
Subject questionnaire | × | × | × | × | × | × | |
End of study | × |